This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dunkle, L. M. Articles by Brock, N. Search for Related Content PubMed PubMed Citation Articles by Dunkle, L. M. Articles by Brock, N. Social Bookmarking                   What's this?

Long-term Follow-up of Ambulatory Management of Osteomyelitis

Department of Pediatrics/Adolescent Medicine, St. Louis University School of Medicine, Cardinal Glennon Memorial Hospital for Children, St. Louis Missouri, University of South Dakota Medical School, Sioux Falls, South Dakota

Norma Brock

Department of Pediatrics/Adolescent Medicine, St. Louis University School of Medicine, Cardinal Glennon Memorial Hospital for Children, St. Louis Missouri, University of South Dakota Medical School, Sioux Falls, South Dakota

Over four years, 50 patients with osteomyelitis (32 classified as acute and 18 as subacute or chronic disease) were treated with oral antibiotics in an ambulatory setting. The profile of clinical and laboratory parameters, including etiologic agents, was similar to previous series. Forty-eight patients initially received parenteral drugs, mean duration 14 days (range 0-36). Oral agents administered at home included cephalosporins, clindamycin, dicloxacillin, peni cillin VK, amoxicillin, and sulfa-trimethoprim. Mean duration of total therapy was 53.2 days (range 16-365). In follow-up, ranging from 12 to 60 months (mean 35), relapses occurred in one patient with acute and one with chronic disease. Both responded to oral treatment. No residual infection has resulted, although clinical and radiographic sequelae remain in six more patients initially termed subacute or chronic.

Long-term follow-up of patients receiving high-dose oral antibiotic therapy for osteomyelitis due to sensitive organisms confirms the safety and efficacy of this mode of treatment and the feasibility of ambulatory management. The outcome after oral therapy is equivalent to that following parenteral therapy. Patients with subacute or chronic disease have a significantly poorer prognosis despite a milder initial illness and longer course of therapy.

Clinical Pediatrics, Vol. 21, No. 11, 650-655 (1982)
DOI: 10.1177/000992288202101102


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Bachur and Z. Pagon Success of Short-Course Parenteral AntibioticTherapy for Acute Osteomyelitis of Childhood Clinical Pediatrics, January 1, 2007; 46(1): 30 - 35. [Abstract] [PDF]

				A. D. Tice, P. A. Hoaglund, and D. A. Shoultz Risk factors and treatment outcomes in osteomyelitis J. Antimicrob. Chemother., May 1, 2003; 51(5): 1261 - 1268. [Abstract] [Full Text] [PDF]

				M. D. Perkins, K. M. Edwards, R. M. Heller, and N. E. Green Neonatal Group B Streptococcal Osteomyelitis and Suppurative Arthritis: Outpatient Therapy Clinical Pediatrics, May 1, 1989; 28(5): 229 - 230. [Abstract] [PDF]

				D. L. Wethers and R. Grover Pitfalls in Diagnosis of Osteomyelitis in Children with Sickle Cell Disease Clinical Pediatrics, September 1, 1983; 22(9): 614 - 618. [Abstract] [PDF]